Skip to main content
Caplight Logo









OxyPrem

OxyPrem

Private
ZurichHealthcare & Life Scienceshttps://www.oxyprem.com/

Last Round

Crowdfunding

Feb 28, 2025

Est. Valuation

$22.6M

Total Funding Raised

$5.86M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

OxyPrem is a healthtech company that develops a medical silicon device to measure brain oxygen levels of preterm infants.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

tissue oximeterbrain oxygen monitoringnear-infrared spectroscopyNIRSpreterm infant monitoringneonatal monitoringpreemie monitoringcerebral oximetryNICUneonatology devicenon-invasive monitoringreusable sensorMedTechmedical devicemedical sensorsHealth IoTCE mark

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OxyPrem Comparables

Compare OxyPrem with similar companies based on industry and business-model similarity.

OxyPrem comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medtronic
74%
Nonin Medical
73%
Masimo Corporation
72%

OxyPrem Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingFeb 28, 2025
GrantJan 1, 2022
GrantAug 7, 2020
AcceleratorAug 2, 2019

Key People

Founding team and executive leadership

Stefan Kleiser

CTO

Executive Team

OxyPrem Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 26, 2026

    Grew 18% QoQ from 17 to 20 employees.

  • Apr 20, 2026

    Monthly visitors grew 3322% MoM, from 9 to 308.

OxyPrem Filings

Explore SEC and related filing metadata, where available.

OxyPrem filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OxyPrem's valuation, stock price, and market status.

Is OxyPrem a public or private company?

OxyPrem is a private company.

What is the current stock price of OxyPrem?

OxyPrem is a private company with no public stock price. No recent secondary market data is available.

How much is OxyPrem worth (valuation)?

OxyPrem's valuation is estimated at $22.6M based on funding round data.

Can I buy OxyPrem stock?

OxyPrem shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OxyPrem's last funding round?

OxyPrem's most recent funding round was Crowdfunding on February 28, 2025.

Who are the main investors in OxyPrem?

Key investors in OxyPrem include Venture Kick.

Will OxyPrem IPO soon?

No public IPO plans have been announced for OxyPrem.

How can I track OxyPrem secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OxyPrem's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersZurich
Employee Range14
Year Founded2018
Last FundingFeb 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?